Impact of Treatment with Direct Acting Antiviral Drugs on Glycemic Control in Patients with Hepatitis C and Diabetes Mellitus.
Pradeep Kumar MadaMatthew E MalusArvin ParvathaneniBing ChenGabriel CastanoSharon AdleyMaureen MooreMichinari HiedaMohammed J AlamMark FeldmanJohn William KingPublished in: International journal of hepatology (2020)
This controlled study demonstrated that treatment of chronic hepatitis C with DAAs results in statistically significant and meaningful reductions in hemoglobin A1C levels in patients with coexisting diabetic mellitus if a SVR is achieved.